Vision Impairment Contributes to Dementia Risk
By Lori Solomon HealthDay Reporter
WEDNESDAY, Sept. 11, 2024 -- The population-attributable fraction of dementia from vision impairments ranges from 4.9 to 19.0 percent, according to a study published online Sept. 5 in JAMA Ophthalmology.
Jason R. Smith, from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues estimated the contribution of vision impairments to dementia using data from the National Health and Aging Trends Study (2,767 community-dwelling Medicare beneficiaries aged 65 years and older).
The researchers found that the population-attributable fraction of prevalent dementia from at least one vision impairment was 19.0 percent. The strongest attributable fraction among all impairments was seen for contrast sensitivity impairment (15.0 percent), followed by near acuity (9.7 percent) and distance acuity (4.9 percent). Population-level dementia-attributable fractions from at least one visual impairment were highest among subpopulations of participants aged 71 to 79 years (24.3 percent), female individuals (26.8 percent), and non-Hispanic White individuals (22.3 percent), with estimates consistent across educational strata.
"While not proving a cause-and-effect relationship, these findings support inclusion of multiple objective measures of vision impairments, including contrast sensitivity and visual acuity, to capture the total potential impact of addressing vision impairment on dementia," the authors write.
Several authors disclosed ties to relevant organizations.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Average Time to Diagnosis Is 3.5 Years Across All Types of Dementia
FRIDAY, Aug. 1, 2025 -- The mean time to diagnosis (TTD) for dementia is 3.5 years across all types of dementia, according to a review published online July 27 in the...
Intranasal Administration of PET Radiotracer Delivers Insulin to Multiple Brain Regions
THURSDAY, July 31, 2025 -- Intranasal administration of [68Ga]Ga-NOTA-insulin is safe and delivers insulin to multiple brain regions, according to a study published online July 23...
Lifestyle Interventions Improve Cognition for At-Risk Older Adults
WEDNESDAY, July 30, 2025 -- Lifestyle interventions improve cognition for older adults at risk for cognitive decline and dementia, with significant benefit seen for a structured...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.